ROYAL BANK OF CANADA - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$0843
+40.5%
0.00%
Q1 2023$0
-100.0%
600
-47.8%
0.00%
Q1 2022$6,000
-82.4%
1,149
-74.1%
0.00%
Q4 2021$34,000
+183.3%
4,433
+176.5%
0.00%
Q3 2021$12,000
-33.3%
1,603
+24.4%
0.00%
Q2 2021$18,000
-33.3%
1,289
+2.9%
0.00%
Q1 2021$27,000
-94.4%
1,253
-95.7%
0.00%
Q4 2020$480,000
+0.8%
28,920
+3.3%
0.00%
Q3 2020$476,00027,995
+164576.5%
0.00%
Q1 2020$0
-100.0%
17
-96.9%
0.00%
Q4 2019$8,000
+300.0%
555
+260.4%
0.00%
Q3 2019$2,000154
+1000.0%
0.00%
Q2 2019$0140.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 3,156,699$2,335,9571.93%
MPM ASSET MANAGEMENT LLC 3,131,388$2,329,7530.97%
MPM BioImpact LLC 3,196,707$2,378,3500.62%
Lion Point Capital, LP 169,283$125,9800.05%
Artal Group S.A. 1,000,000$7440.04%
Cormorant Asset Management, LP 540,600$4020.03%
KENNEDY CAPITAL MANAGEMENT LLC 529,934$394,3770.01%
Orbimed Advisors 621,218$462,3100.01%
Tekla Capital Management LLC 259,910$193,4250.01%
CM WEALTH ADVISORS LLC 50,354$290.01%
View complete list of HARPOON THERAPEUTICS INC shareholders